NCT00093626 · Interventional trial
Sorafenib in Treating Patients With Persistent or Recurrent Ovarian Epithelial or Peritoneal Cancer
Overall registry status Completed
Phase 2
Conditions Primary Peritoneal Carcinoma, Recurrent Ovarian Carcinoma
Delaware Valley sites
- Gynecologic Oncology Group · Philadelphia, PA · Philadelphia County
First posted
Registry updated
Added to the directory